Overview
BPC-157 is studied in research involving tissue repair, recovery, and protective signaling pathways. Researchers commonly investigate its relationship with connective tissue and biological processes involved in recovery. Alpha Tides supplies BPC-157 as a 10mg lyophilized powder for laboratory research use.
Technical Research Details
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids derived from a protective protein found in human gastric juice. It is one of the most extensively studied repair-pathway compounds in the preclinical literature, with published research spanning gastrointestinal models, musculoskeletal tissue repair, angiogenesis, and inflammatory signaling.
Research Applications
- Gastrointestinal research: Mucosal integrity, ulcer models, and inflammatory bowel disease pathway studies
- Musculoskeletal tissue models: Tendon, ligament, and muscle repair studies in preclinical models
- Angiogenesis research: VEGFR2 upregulation and blood vessel formation signaling studies
- Inflammatory signaling: Cytokine cascade modulation in inflammation models
- Neurological research: Preliminary studies on neuroprotective and nerve regeneration pathways
- Wound healing models: In vitro and preclinical dermal repair and tissue remodeling studies
Research Notes
BPC-157 enhances growth hormone receptor expression and modulates several pathways involved in cell growth and angiogenesis while reducing pro-inflammatory cytokines. One of its most studied properties is its influence on new blood vessel formation — research has shown upregulation of VEGFR2 expression in response to BPC-157, suggesting a role in promoting vascular growth signaling.
The bulk of BPC-157 research has been conducted in preclinical rodent models. Across multiple published studies, BPC-157 improved outcomes in inflammatory bowel disease models, GI ulcer models, NSAID-induced mucosal injury, and wound repair protocols. More recently, interest has expanded into musculoskeletal research — preclinical studies consistently highlight activity in tendon, muscle, and ligament healing models, including under inflammatory or compromised conditions.
BPC-157 has a notable stability profile among research compounds — it demonstrates resistance to degradation in gastric acid in preclinical studies, which has contributed to its use in GI tract research models.
Storage Notes
- Before reconstitution: Store lyophilized vials at −20°C, protected from light and moisture. Allow to reach room temperature before opening.
- After reconstitution: Refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.
- Recommended solvent: Bacteriostatic water.
Documentation
Supplier-provided laboratory documentation is available for this product. This report was not independently commissioned by Alpha Tides PNW — see our Certificates of Analysis page for the full document and source notes.
Related Research
- How to Store Research Compounds Properly — Storage protocols for lyophilized compounds
- How to Reconstitute Lyophilized Compounds — Step-by-step reconstitution guide
- How to Stack Compounds for Research — Combination protocol guidance
- Research Hub — Full library of compound guides and research references
- What Is BPC-157? A Researcher’s Guide — Mechanism overview and research background for this compound
- Deadpool Stack — A separate multi-component formulation that includes BPC-157 alongside Cartalax and TB-500
BPC-157 is intended strictly for laboratory research by qualified professionals. It is not FDA approved and is not for human or animal use. By purchasing, the buyer confirms the product will be used solely for in vitro research in compliance with all applicable laws and regulations.
Laboratory Testing
Certificate available
